How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Veterinary Anesthesia Mask Market
- By Material: Silicone, PVC (Polyvinyl Chloride), Rubber, Polycarbonate
- By Animal Type: Small Animals, Large Animals, Equine, Avian
- By Mask Design: Circular Mask, Cone Mask, Rebreathing Mask, Non-Rebreathing Mask
- By Connection Type: Standard 15 mm Connector, Standard 22 mm Connector, Universal Connector
- By Usage Setting: Veterinary Clinics, Research Laboratories, Animal Hospitals, Field Use
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Silicone leads By Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Veterinary Anesthesia Mask Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Material 4
Animal Type 4
Mask Design 4
Connection Type 3
Usage Setting 4
Companies profiled
Merial (a Boehringer Ingelheim company)
Zoetis Inc.
Becton Dickinson and Company (BD)
Covetrus Inc.
Vetoquinol SA
Midmark Corporation
Henry Schein Inc.
Jorgensen Laboratories Inc.
Kent Scientific Corporation
MediVet International
Patterson Companies Inc.
Dechra Pharmaceuticals PLC
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Merial (a Boehringer Ingelheim company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Zoetis Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Covetrus Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Vetoquinol SA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Midmark Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Henry Schein Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Jorgensen Laboratories Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Kent Scientific Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →MediVet International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Patterson Companies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Dechra Pharmaceuticals PLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Bionet America Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →VetEquip Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Medi-Equip
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,963M by 2033 · 8.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Silicone41.9
- PVC (Polyvinyl Chloride)15.5
- Rubber20.3
- Polycarbonate22.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$680.6M → $1,279M · 8.2%
Europe$474.4M → $884.0M · 8.1%
Asia Pacific$433.1M → $834.4M · 8.5%
Latin America$268.1M → $563.1M · 9.7%
Middle East and Africa$206.2M → $418.4M · 9.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.472026
8.472027
8.492028
8.502029
8.502030
8.522031
8.542032
8.542033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Merial (a Boehringer Ingelheim company)22.8
- Zoetis Inc.12.6
- Becton Dickinson and Company (BD)12.1
- Covetrus Inc.4.3
- Vetoquinol SA8.7
- Midmark Corporation11.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material28.6%
Animal Type9.8%
Mask Design16.4%
Connection Type20.5%
Usage Setting24.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.1
- Europe22.2
- Asia Pacific21.0
- Latin America14.2
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Merial (a Boehringer Ingelheim company) | 91 | 75 | 80 | 90 | 80 | 88 | 84 |
| Zoetis Inc. | 69 | 91 | 87 | 85 | 86 | 72 | 82 |
| Becton Dickinson and Company (BD) | 68 | 82 | 66 | 68 | 86 | 87 | 76 |
| Covetrus Inc. | 73 | 81 | 59 | 82 | 70 | 70 | 73 |
| Vetoquinol SA | 69 | 57 | 75 | 51 | 74 | 68 | 66 |
| Midmark Corporation | 58 | 48 | 47 | 61 | 56 | 66 | 56 |
| Henry Schein Inc. | 60 | 52 | 46 | 45 | 49 | 57 | 52 |
| Jorgensen Laboratories Inc. | 59 | 45 | 53 | 55 | 44 | 58 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Merial (a Boehringer Ingelheim company)
- Zoetis Inc.
- Becton Dickinson and Company (BD)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Merial (a Boehringer Ingelheim company) | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Zoetis Inc. | ◐ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Becton Dickinson and Company (BD) | ✓ | ✓ | ✓ | − | ◐ | ✓ |
| Covetrus Inc. | ◐ | ✓ | ◐ | ◐ | ✓ | − |
| Vetoquinol SA | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Midmark Corporation | − | − | ◐ | − | ◐ | − |
| Henry Schein Inc. | ◐ | − | − | ◐ | ◐ | − |
| Jorgensen Laboratories Inc. | ◐ | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Merial (a Boehringer Ingelheim company)84
2Zoetis Inc.82
3Becton Dickinson and Company (BD)76
4Covetrus Inc.73
5Vetoquinol SA66
6Midmark Corporation56
7Henry Schein Inc.52
8Jorgensen Laboratories Inc.52
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Merial (a Boehringer Ingelheim company)Zoetis Inc.
Challenger2
Strong scale, closing on the leaders.
Becton Dickinson and Company (BD)Covetrus Inc.
Contender1
Focused players with pockets of strength.
Vetoquinol SA
Niche3
Specialists in a single segment or region.
Midmark CorporationHenry Schein Inc.Jorgensen Laboratories Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material in North America, then scale across Veterinary Anesthesia Mask Market — a $44M beachhead inside a $679M market.
Beachhead (SOM)$44Mobtainable near-term
Serviceable (SAM)$282Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Silicone
Best fit — highest urgency & budget in Material.
Economic buyer78 fit
PVC (Polyvinyl Chloride)
Strong fit — clear ROI and a fast path to value.
End user69 fit
Rubber
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Animal Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Mask Design
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Veterinary Anesthesia Mask Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified25%
Evaluation15%
Closed-won7%
$9.7KCAC
$36KLTV
3.7:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Veterinary Anesthesia Mask Market is a durable-growth opportunity — $8.58B by 2033, compounding at 8.2%.
TAM · 2025$4.56Btoday
TAM · 2033$8.58Bforecast
CAGR8.2%2027–2033
Cumulative$57.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.58BTotal addressable market
SAM$3.28BServiceable available market
SOM$588MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.2% CAGR
Demand compounds through 2033, outpacing GDP across Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.58BLarge & growingTAM by 2033 at 8.2% CAGR
$3.28BServiceable nowreachable with today’s model
$588MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.69BBear5.3% CAGR
$8.58BBase8.2% CAGR
$11.0BBull10.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Animal Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Veterinary Anesthesia Mask Market — a $1.18B market by 2033. Plan: grow share from 10.4% to 18.6%.
Market size · 2033$1.18Btotal addressable
Market CAGR7.9%2027–2033
Target share18.6%from 10.4% today
Revenue ambition$219Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.4% | 18.6% | At risk |
| Revenue | $123M | $219M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 36.5% | 45.0% | On track |
| Customer retention | 84.9% | 93.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Animal Type capability
A defensible second engine — invest in Animal Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Animal Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $26M capacity & capability investment
- Greenlight bolt-on M&A in Animal Type
- Authorise North America expansion plan
- Fund R&D program for Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Veterinary Anesthesia Mask Market conversation — a $3.25B market you can size, segment and defend in minutes.
Market size · 2033$3.25Btotal opportunity
Growth5.6%CAGR to 2033
Addressable buyers1,512+accounts in scope
Typical ROI6.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material
Goal Grow share in Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.1×return on cost, year one
< 4 mopayback period
$56K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Merial (a Boehringer Ingelheim company)Zoetis Inc.Becton Dickinson and Company (BD)Covetrus Inc.Vetoquinol SAMidmark CorporationHenry Schein Inc.Jorgensen Laboratories Inc.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Veterinary Anesthesia Mask Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Veterinary Anesthesia Mask Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Veterinary Anesthesia Machine Flowmeter Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportVeterinary Anesthesia Injection Machines Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportVeterinary Anesthesia Evaporators Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportVeterinary Anesthesia Drug Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportVeterinary Anesthesia Breathing Machine Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportVeterinary Anaesthesia Machines Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportVeterinary Active Pharmaceutical Ingredients Manufacturing Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportVeterinary Active Pharmaceutical Ingredients (API) Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportVeterinary Abdominal Endoscopy Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportVeterinarian Examining Otoscopes Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportVeterinarian Examining Auriscope Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportVet Ear Examination Device Market
Market size, share, segmentation and regional forecast.
$942M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.